Domain Not Resolving

HSTS

Google Maps

Amazon

nginx

IPv6

Person Schema

Facebook Sharer

CrUX Top 50m

Amazon Virginia Region

SVP & COO

Bram Goorden

Project Management CEO Office

Donatienne Noez

Co-Founder and CEO

Jurgi Camblong

Chief Revenue Officer (CRO)

Ken Freedman

Chief Business Officer

Lara Hashimoto

Chief Financial Officer

Ross Muken

Vice President of Sales Operations

David Norcia

VP, Talent Management

John Gilleeny (EdD, CPTD, SPHR)

VP Business Development

Kevin Puylaert

Vice President, BioPharma

Michael Cerio

Troy Cox

Vincent Ossipow

Antoine Duchateau

Michael Schenck

Lars Steinmetz

James Wise

Milton Silva-Craig

Andrew Kanter

Co-Founder & CEO

Manuela Valente

SVP, Chief People Officer

Valentin Matillon

SVP - Chief Financial Officer

Zhenyu Xu

Chief Scientific Officer

Chief Revenue Officer

Daan Van Well

Chief Legal Officer | General Counsel

Boston Companies that Exited

East Coast Public Companies With Less Than $1B in Revenue

Greater Boston Area Biotechnology Companies

East Coast Biotechnology Companies

SOPHiA GENETICS is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products and services are currently used by more than 780 hospital, laboratory and biopharma institutions globally.

Perceptive Advisors

Post-IPO Debt - SOPHiA GENETICS

aMoon Fund

Series F - SOPHiA GENETICS

Generation Investment Management

Series E - SOPHiA GENETICS

Balderton Capital

Series D - SOPHiA GENETICS

Marc Coucke

Series C - SOPHiA GENETICS

Invoke Capital

Series B - SOPHiA GENETICS

Series A - SOPHiA GENETICS

Foundation for Innovation and Technology (FIT)

Debt Financing - SOPHiA GENETICS

Medical and Beauty Services and Agricultural Services

Boston

Massachusetts

United States

North America

SOPHiA GENETICS

SOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024

SOPHiA GENETICS Reports Third Quarter 2024 Results

SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing

Sophia Genetics announces collaboration agreement with AstraZeneca

Sophia Genetics cuts FY24 revenue view to $65M-$67M from $78M-$81M

SOPHiA GENETICS Announces L'hôpital Universitaire Avicenne is Live on SOPHiA DDM™

SOPHiA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix

SOPHIA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix

A cloud-based platform that uses AI and machine learning to analyze health data for insights across multiple disease areas.

Solutions for analyzing genomic data related to oncology, rare and inherited diseases, cardiology, neurology, and metabolism.

Services for the biopharmaceutical industry, leveraging genomic data and AI analytics to support drug development.

A network of healthcare institutions sharing knowledge and insights to facilitate variant interpretation.

Software for variant annotation, exploration, and visualization on a genomic scale.

A tool for interpreting tumor molecular profiles, providing clinical associations and supporting decision-making.

Switzerland

Europe

Brazil

South America

South Korea

Asia

France

HTML5

Lightbox

Microsoft Outlook

Cloudflare CDN

Vimeo

Bootstrap

Office 365

jQuery

Google Fonts

Adobe Fonts

SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.

SOPHiA GENETICS SA

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general	Mar 8, 2024 12:04 PM	13e5220e
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Mar 8, 2024 12:04 PM	9b4277fc
company summary	general
signals	general
crunchbase trigger	general	Nov 25, 2024 9:06 AM	cbd80fa6
crunchbase profile	general	Nov 25, 2024 11:35 AM	da072a9e
li profile	general
translate crunchbase fundingrounds	general	Nov 25, 2024 2:17 PM	ee473fdc
peers	general
news basic	general	Mar 8, 2024 12:04 PM	8597a40e
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:SOPHIAGENETICS

Sophia Genetics

Last Close

3.94

14/02 21:00

Market Cap

299.42M

Beta: -

Volume Today

138.45K

Avg: -